President and COO

VP, Chief Legal Officer

Stryker designs, manufactures, and markets an array of medical equipment, instruments, consumable supplies, and implantable devices. The product portfolio includes hip and knee replacements, extremities, endoscopy systems, operating room equipment, embolic coils, hospital beds and gurneys, and orthopedic robotics. Stryker remains one of the three largest competitors in reconstructive orthopedic implants and holds the leadership position in operating room equipment. Roughly one-fourth of Stryker's total revenue currently comes from outside the United States.

Institution	Shares	Value	Change
Greenleaf Trust	15,228,545	$4.8B	DECREASED
Alecta Tjanstepension Omsesidigt	547,900	$173M	UNCHANGED
Fenimore Asset Management	547,340	$172M	INCREASED
Abn Amro Investment Solutions	414,338	$130M	INCREASED
Rathbones Group	353,461	$111M	INCREASED

Insider	Type	Shares	Value	Date
Spencer S Stiles (President and COO)	GIFT	1,607		2026-06-01
Robert S Fletcher (VP, Chief Legal Officer)	SELL	125	$39K	2026-05-28
Robert S Fletcher (VP, Chief Legal Officer)	SELL	258	$80K	2026-05-28
Robert S Fletcher (VP, Chief Legal Officer)	SELL	1,067	$328K	2026-05-28
Robert S Fletcher (VP, Chief Legal Officer)	SELL	2,809	$861K	2026-05-28

Member	Type	Amount	Date
Alan Armstrong (Republican)	SALE	$15,001 - $50,000	2026-03-27
Thomas H. Kean	SALE	$1,001 - $15,000	2026-06-02
Ro Khanna (Democrat)	PURCHASE	$15,001 - $50,000	2026-04-13

Stryker Corporation (SYK) Ownership & Trading Activity

Top Institutional Holders

Recent Insider Trades

Recent Congressional Trades